CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $635 from $684 and keeps an Overweight rating on the shares following ...

Intuitive Surgical is the world’s leading robotic surgery company, and it has a solid earnings track record. The company ...